ZFYVE19 polyclonal, anti-human
€305.00
In stock
SKU
BS61739
Background:
Zinc finger proteins contain DNA-binding domains and have a wide variety of functions, most of which encompass some form of transcriptional activation or repression. ZFYVE19 (zinc finger, FYVE domain containing 19), also known as MPFYVE (MLL partner containing FYVE domain), is a 471 amino acid protein that contains one FYVE-type zinc finger. Expressed in heart, brain, kidney, skeletal muscle and liver, ZFYVE19 may participate in transcriptional regulation events within the cell. Defects in the gene encoding ZFYVE19 are associated with acute myeloblastic leukemia (AML), a rapidly progressing cancer of the myeloid line of white blood cells that is characterized by fever, anemia, bone pain, shortness of breath and frequent infections. Three isoforms of ZFYVE19 exist due to alternative splicing events.
Alternative Name:
Abscission/NoCut checkpoint regulator, ANCHR, MLL partner containing FYVE domain, Zinc finger FYVE domain-containing protein 19, ZFYVE19, ANCHR, MPFYVE
Application Dilution: WB: 1:500~1:1000
Specificity: ZFYVE19 polyclonal antibody detects endogenous levels of ZFYVE19 protein.
Immunogen:
Synthetic peptide, corresponding to amino acids 300-350 of Human ZFYVE19.
MW: ~ 52 kDa
Swis Prot.: Q96K21
Purification & Purity:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Format:
1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.3.
Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For research use only, not for use in diagnostic procedure.
Zinc finger proteins contain DNA-binding domains and have a wide variety of functions, most of which encompass some form of transcriptional activation or repression. ZFYVE19 (zinc finger, FYVE domain containing 19), also known as MPFYVE (MLL partner containing FYVE domain), is a 471 amino acid protein that contains one FYVE-type zinc finger. Expressed in heart, brain, kidney, skeletal muscle and liver, ZFYVE19 may participate in transcriptional regulation events within the cell. Defects in the gene encoding ZFYVE19 are associated with acute myeloblastic leukemia (AML), a rapidly progressing cancer of the myeloid line of white blood cells that is characterized by fever, anemia, bone pain, shortness of breath and frequent infections. Three isoforms of ZFYVE19 exist due to alternative splicing events.
Alternative Name:
Abscission/NoCut checkpoint regulator, ANCHR, MLL partner containing FYVE domain, Zinc finger FYVE domain-containing protein 19, ZFYVE19, ANCHR, MPFYVE
Application Dilution: WB: 1:500~1:1000
Specificity: ZFYVE19 polyclonal antibody detects endogenous levels of ZFYVE19 protein.
Immunogen:
Synthetic peptide, corresponding to amino acids 300-350 of Human ZFYVE19.
MW: ~ 52 kDa
Swis Prot.: Q96K21
Purification & Purity:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Format:
1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.3.
Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For research use only, not for use in diagnostic procedure.
| Is Featured? | No |
|---|
Write Your Own Review